Compare WST & SATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WST | SATS |
|---|---|---|
| Founded | 1923 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 17.8B |
| IPO Year | N/A | 2007 |
| Metric | WST | SATS |
|---|---|---|
| Price | $271.75 | $104.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 5 |
| Target Price | ★ $346.78 | $71.80 |
| AVG Volume (30 Days) | 628.4K | ★ 5.8M |
| Earning Date | 10-23-2025 | 11-06-2025 |
| Dividend Yield | ★ 0.32% | N/A |
| EPS Growth | ★ 0.17 | N/A |
| EPS | ★ 6.75 | N/A |
| Revenue | $3,017,900,000.00 | ★ $15,175,913,000.00 |
| Revenue This Year | $7.01 | N/A |
| Revenue Next Year | $6.20 | N/A |
| P/E Ratio | $40.37 | ★ N/A |
| Revenue Growth | ★ 4.92 | N/A |
| 52 Week Low | $187.43 | $14.90 |
| 52 Week High | $348.90 | $109.44 |
| Indicator | WST | SATS |
|---|---|---|
| Relative Strength Index (RSI) | 48.81 | 88.64 |
| Support Level | $263.38 | $72.54 |
| Resistance Level | $285.54 | $75.37 |
| Average True Range (ATR) | 7.72 | 4.83 |
| MACD | -0.62 | 3.67 |
| Stochastic Oscillator | 46.91 | 88.37 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
Satellite television provides the bulk of EchoStar's revenue. The firm serves about 5 million US satellite customers, about 10% of the traditional television market. It also serves 2 million customers under the Sling brand. EchoStar has also amassed an extensive portfolio of spectrum licenses and is building a nationwide wireless network. It acquired Sprint's prepaid business, serving approximately 7 million customers, primarily under the Boost brand. The firm has agreed to sell a portion of its wireless licenses to AT&T and will rely heavily on the AT&T network to serve customers. EchoStar's legacy businesses provide satellite telecom services and equipment to businesses and consumers, including about 800,000 internet customers.